Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The aryl hydrocarbon receptor suppresses immunity to oral squamous cell carcinoma through immune checkpoint regulation
Jessica E. Kenison, Zhongyan Wang, Kangkang Yang, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 19
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Indoleamine 2,3-dioxygenase (IDO) inhibitors and cancer immunotherapy
Yu Fujiwara, Shumei Kato, Mary Nesline, et al.
Cancer Treatment Reviews (2022) Vol. 110, pp. 102461-102461
Open Access | Times Cited: 175
Role of indoleamine 2,3-dioxygenase 1 (IDO1) and kynurenine pathway in the regulation of the aging process
Antero Salminen
Ageing Research Reviews (2022) Vol. 75, pp. 101573-101573
Open Access | Times Cited: 91
Functions of the aryl hydrocarbon receptor (AHR) beyond the canonical AHR/ARNT signaling pathway
Natalie C. Sondermann, Sonja Faßbender, Frederick Hartung, et al.
Biochemical Pharmacology (2022) Vol. 208, pp. 115371-115371
Open Access | Times Cited: 72
The role of the immunosuppressive PD-1/PD-L1 checkpoint pathway in the aging process and age-related diseases
Antero Salminen
Journal of Molecular Medicine (2024) Vol. 102, Iss. 6, pp. 733-750
Open Access | Times Cited: 23
AHR signaling is induced by infection with coronaviruses
Federico Giovannoni, Zhaorong Li, Federico Remes-Lenicov, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 67
The cancer-immune dialogue in the context of stress
Yuting Ma, Guido Kroemer
Nature reviews. Immunology (2023) Vol. 24, Iss. 4, pp. 264-281
Closed Access | Times Cited: 34
PD-L1 positive astrocytes attenuate inflammatory functions of PD-1 positive microglia in models of autoimmune neuroinflammation
Mathias Linnerbauer, Tobias A. Beyer, Lucy Nirschl, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 25
Metabolic landscape of head and neck squamous cell carcinoma informs a novel kynurenine/Siglec‐15 axis in immune escape
X Zhang, Jianbo Shi, Shufang Jin, et al.
Cancer Communications (2024) Vol. 44, Iss. 6, pp. 670-694
Open Access | Times Cited: 10
The aryl hydrocarbon receptor controls IFN-γ-induced immune checkpoints PD-L1 and IDO via the JAK/STAT pathway in lung adenocarcinoma
Megan Snyder, Zhongyan Wang, Brian Lara, et al.
The Journal of Immunology (2025)
Open Access | Times Cited: 1
Discovery and Characterization of a Novel Aryl Hydrocarbon Receptor Inhibitor, IK-175, and Its Inhibitory Activity on Tumor Immune Suppression
Karen McGovern, Alfredo Castro, Jill Cavanaugh, et al.
Molecular Cancer Therapeutics (2022) Vol. 21, Iss. 8, pp. 1261-1272
Open Access | Times Cited: 30
Deciphering the roles of aryl hydrocarbon receptor (AHR) in regulating carcinogenesis
Zhi Xiong Chong, Chean Yeah Yong, Han Kiat Ong, et al.
Toxicology (2023) Vol. 495, pp. 153596-153596
Open Access | Times Cited: 18
The Aryl Hydrocarbon Receptor: Impact on the Tumor Immune Microenvironment and Modulation as a Potential Therapy
Brian D. Griffith, Timothy L. Frankel
Cancers (2024) Vol. 16, Iss. 3, pp. 472-472
Open Access | Times Cited: 8
Sustained AhR activity programs memory fate of early effector CD8 + T cells
Huafeng Zhang, Zhuoshun Yang, Yuan Wu, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 11
Open Access | Times Cited: 7
Aryl hydrocarbon receptor/nuclear factor E2‐related factor 2 (AHR/NRF2) signalling: A novel therapeutic target for atopic dermatitis
Jonwei Hwang, Edita M. Newton, Jennifer L. Hsiao, et al.
Experimental Dermatology (2022) Vol. 31, Iss. 4, pp. 485-497
Open Access | Times Cited: 26
Human Papilloma Virus Positive Oropharyngeal Squamous Cell Carcinoma and the Immune System: Pathogenesis, Immunotherapy and Future Perspectives
Alan Soo Beng Khoo, Michael Boyer, Zuhayr Jafri, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2798-2798
Open Access | Times Cited: 6
The aryl hydrocarbon receptor as a tumor modulator: mechanisms to therapy
Kanita A. Chaudhry, Anna Bianchi
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
The mouse oral carcinoma (MOC) model: A 10-year retrospective on model development and head and neck cancer investigations
Michihisa Kono, Shin Saito, Ann Marie Egloff, et al.
Oral Oncology (2022) Vol. 132, pp. 106012-106012
Open Access | Times Cited: 21
Cell-intrinsic view of the aryl hydrocarbon receptor in tumor immunity
Joseph Dean, Liang Zhou
Trends in Immunology (2022) Vol. 43, Iss. 3, pp. 245-258
Open Access | Times Cited: 20
Mature dendritic cells enriched in regulatory molecules may control regulatory T cells and the prognosis of head and neck cancer
Kiyoshi Minohara, Masaki Imai, Takuma Matoba, et al.
Cancer Science (2022) Vol. 114, Iss. 4, pp. 1256-1269
Open Access | Times Cited: 20
Environmental exposure and the role of AhR in the tumor microenvironment of breast cancer
Colleen Sweeney, Gwendal Lazennec, Christoph F.A. Vogel
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 19
The Aryl Hydrocarbon Receptor in the Pathogenesis of Environmentally-Induced Squamous Cell Carcinomas of the Skin
Christian Vogeley, Katharina M. Rolfes, Jean Krutmann, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 19
Peripheral blood leukocyte signatures as biomarkers in relapsed ovarian cancer patients receiving combined anti‐CD73/anti‐PD‐L1 immunotherapy in arm A of the NSGO‐OV‐UMB1/ENGOT‐OV30 trial
Luka Tandarić, Annika Auranen, Katrin Kleinmanns, et al.
Molecular Oncology (2025)
Open Access
The Janus-facedness of the aryl hydrocarbon receptor pathway Report of the 6th International AHR Meeting: Research, Prevention, Therapy
Thomas Haarmann‐Stemmann, Doreen Reichert, Xavier Coumoul, et al.
Biochemical Pharmacology (2025), pp. 116808-116808
Open Access
Deciphering the metabolic landscape of colorectal cancer through the lens of AhR-mediated intestinal inflammation
Jasmine Swain, Preeti Preeti, Chandana Mohanty, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Loss of aryl hydrocarbon receptor reduces pancreatic tumor growth by increasing immune cell infiltration
Vinicius Kannen, Ninni Elise Olafsen, Siddhartha Das, et al.
Biochemical Pharmacology (2025), pp. 116872-116872
Closed Access
Page 1 - Next Page

Scroll to top